Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Glucantime plus cryotherapy vs cryotherapy alone for cutaneous leishmaniasis
IRCT20170723035248N4Phase 3Completed
- Sponsor
- Qom University of Medical Sciences
- Start
- Mar 2013
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 3 trial of meglumine antimoniate in cutaneous leishmaniasis (CL) (2 arms), sponsored by Qom University of Medical Sciences. Started Mar 2013; status: completed.
02
Drugs
meglumine antimoniate
03
Conditions
cutaneous leishmaniasis (CL)
Beyond the preview
Go deeper on IRCT20170723035248N4.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on IRCT20170723035248N4.